Indeed, growth factor signaling via EGFR and downstream MAPK/PI3K cascades is a critical driver of cell proliferation and drug sensitivity in colorectal cancer [59,60], and its attenuation is consistent with the reduced responsiveness of TRIM28-KO cells to cytotoxic agents. Here, EGFR is linked to colorectal cancer.